Global Burden of Cardiovascular Diseases and Risks, 1990-2022.
作者信息
Mensah George A, Fuster Valentin, Murray Christopher J L, Roth Gregory A
机构信息
Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
出版信息
J Am Coll Cardiol. 2023 Dec 19;82(25):2350-2473. doi: 10.1016/j.jacc.2023.11.007.
Abstract
摘要
相似文献
1
Global Burden of Cardiovascular Diseases and Risks, 1990-2022.1990 - 2022年心血管疾病及其风险的全球负担
J Am Coll Cardiol. 2023 Dec 19;82(25):2350-2473. doi: 10.1016/j.jacc.2023.11.007.
2
The Global Burden of Cardiovascular Diseases and Risks: A Compass for Global Action.心血管疾病及其风险的全球负担：全球行动指南。
J Am Coll Cardiol. 2020 Dec 22;76(25):2980-2981. doi: 10.1016/j.jacc.2020.11.021.
3
The burden of cardiovascular risk factors: a global perspective.心血管危险因素的负担：全球视角
Eur Heart J. 2022 Aug 7;43(30):2817-2820. doi: 10.1093/eurheartj/ehac430.
4
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990-2017.意大利心血管疾病负担和血管危险因素的趋势：1990-2017 年全球疾病负担研究。
Eur J Prev Cardiol. 2021 May 8;28(4):385-396. doi: 10.1177/2047487320949414.
5
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年79种行为、环境与职业及代谢风险或风险群组的全球、区域和国家比较风险评估：全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1659-1724. doi: 10.1016/S0140-6736(16)31679-8.
6
Balancing the scales of adversity: a socioecological approach to reducing the global burden of stroke and cardiovascular disease.平衡逆境天平：减轻全球中风和心血管疾病负担的社会生态方法
Lancet Neurol. 2023 Dec;22(12):1094-1096. doi: 10.1016/S1474-4422(23)00386-1. Epub 2023 Oct 9.
7
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家 84 种行为、环境、职业和代谢风险以及 195 个国家和地区 1990 至 2017 年风险簇的比较风险评估：全球疾病负担研究 2017 系统分析。
Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8.
8
Analysis of the global burden of cardiovascular diseases linked to exposure to ambient particulate matter pollution from 1990 to 2019.分析 1990 年至 2019 年与暴露于环境细颗粒物污染有关的心血管疾病的全球负担。
Front Public Health. 2024 Oct 2;12:1391836. doi: 10.3389/fpubh.2024.1391836. eCollection 2024.
9
The burden of Cardiovascular diseases in Jordan: a longitudinal analysis from the global burden of disease study, 1990-2019.约旦的心血管疾病负担：来自全球疾病负担研究，1990-2019 年的纵向分析。
BMC Public Health. 2024 Mar 21;24(1):879. doi: 10.1186/s12889-024-18316-0.
10
Systematic Analysis of the Global, Regional and National Burden of Cardiovascular Diseases from 1990 to 2017.全球、区域和国家心血管疾病负担的系统分析：1990-2017 年
J Epidemiol Glob Health. 2022 Mar;12(1):92-103. doi: 10.1007/s44197-021-00024-2. Epub 2021 Dec 13.
引用本文的文献
1
Healthy Lifestyle and Its Relationship with Health-Related Quality of Life in Cardiovascular Patients: A Cross-Sectional Study.健康生活方式及其与心血管疾病患者健康相关生活质量的关系：一项横断面研究。
J Lifestyle Med. 2025 Aug 31;15(2):57-65. doi: 10.15280/jlm.2025.15.2.57.
2
Development of a blood-based lipidomic fat quality score for the risk of ischemic stroke.基于血液脂质组学的缺血性中风风险脂肪质量评分的开发。
Eur Stroke J. 2025 Sep 3:23969873251367250. doi: 10.1177/23969873251367250.
3
Lipid overload meets S-palmitoylation: a metabolic signalling nexus driving cardiovascular and heart disease.脂质过载与S-棕榈酰化相遇：驱动心血管疾病和心脏病的代谢信号枢纽。
Cell Commun Signal. 2025 Sep 2;23(1):392. doi: 10.1186/s12964-025-02398-3.
4
Prevalence, Clinical Characteristics and Prognosis of Vascular Disease in Valvular Heart Surgery: A Multi-Centre Study.心脏瓣膜手术中血管疾病的患病率、临床特征及预后：一项多中心研究
Glob Heart. 2025 Aug 28;20(1):71. doi: 10.5334/gh.1462. eCollection 2025.
5
The second survey of the Saudi Acute Myocardial Infarction Registry Program: Main results and temporal changes in care (STARS-2 program).沙特急性心肌梗死注册项目的第二次调查：护理的主要结果及时间变化（STARS - 2项目）
PLoS One. 2025 Sep 2;20(9):e0331215. doi: 10.1371/journal.pone.0331215. eCollection 2025.
6
A systematic review and dose-response meta-analysis of red blood cell distribution width to albumin ratio as mortality predictor in cardiovascular disease.红细胞分布宽度与白蛋白比值作为心血管疾病死亡率预测指标的系统评价和剂量反应荟萃分析
Sci Rep. 2025 Sep 1;15(1):32053. doi: 10.1038/s41598-024-81876-z.
7
Clonal Hematopoiesis and Risk of New-Onset Myocarditis and Pericarditis.克隆性造血与新发心肌炎和心包炎的风险
JAMA Cardiol. 2025 Aug 30. doi: 10.1001/jamacardio.2025.3369.
8
Associations of depressive symptoms and social dysfunction with happiness in adults with cardiovascular disease: a cross-sectional study.心血管疾病成人患者中抑郁症状和社交功能障碍与幸福感的关联：一项横断面研究
BMC Psychol. 2025 Aug 29;13(1):980. doi: 10.1186/s40359-025-03044-w.
9
The Impact of Intelligent Medical Systems Combined with Interdisciplinary Care Teams on Home-Based Elderly Population's Quality of Life.智能医疗系统与跨学科护理团队相结合对居家老年人群生活质量的影响。
J Multidiscip Healthc. 2025 Aug 22;18:5161-5172. doi: 10.2147/JMDH.S542529. eCollection 2025.
10
Prognostic role of angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with acute myocardial infarction.1型血管紧张素II受体和A型内皮素-1受体激动性自身抗体在急性心肌梗死患者中的预后作用
Front Cardiovasc Med. 2025 Aug 12;12:1515693. doi: 10.3389/fcvm.2025.1515693. eCollection 2025.
本文引用的文献
1
2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease.2023 年世界心脏联盟风湿性心脏病超声心动图诊断指南。
Nat Rev Cardiol. 2024 Apr;21(4):250-263. doi: 10.1038/s41569-023-00940-9. Epub 2023 Nov 2.
2
Atrial fibrillation: a contemporary update.心房颤动：现代更新。
Clin Med (Lond). 2023 Sep;23(5):437-441. doi: 10.7861/clinmed.2023-23.5.Cardio2. Epub 2023 Sep 29.
3
The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.2023 年杜克-国际心血管感染性疾病学会感染性心内膜炎标准：修改后的杜克标准更新。
Clin Infect Dis. 2023 Aug 22;77(4):518-526. doi: 10.1093/cid/ciad271.
4
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2022 ACC/AHA 血管疾病诊断与管理指南：美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2022 Dec 13;80(24):e223-e393. doi: 10.1016/j.jacc.2022.08.004. Epub 2022 Nov 2.
5
The Burden of Proof studies: assessing the evidence of risk.举证责任研究：评估风险证据。
Nat Med. 2022 Oct;28(10):2038-2044. doi: 10.1038/s41591-022-01973-2. Epub 2022 Oct 10.
6
Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study.收缩压升高对缺血性心脏病的影响：证据负担研究。
Nat Med. 2022 Oct;28(10):2056-2065. doi: 10.1038/s41591-022-01974-1. Epub 2022 Oct 10.
7
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association.下肢外周动脉疾病：当代流行病学、管理差距与未来方向：美国心脏协会科学声明。
Circulation. 2021 Aug 31;144(9):e171-e191. doi: 10.1161/CIR.0000000000001005. Epub 2021 Jul 28.
8
Public health utility of cause of death data: applying empirical algorithms to improve data quality.死因数据的公共卫生效用：应用经验算法改善数据质量。
BMC Med Inform Decis Mak. 2021 Jun 2;21(1):175. doi: 10.1186/s12911-021-01501-1.
9
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.《PRISMA 2020声明：报告系统评价的更新指南》
Syst Rev. 2021 Mar 29;10(1):89. doi: 10.1186/s13643-021-01626-4.
10
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2021 Feb 2;77(4):e25-e197. doi: 10.1016/j.jacc.2020.11.018. Epub 2020 Dec 17.
Zotero 插件